First parcel September 2018 during the little volume fiasco that got it on the radar for me.
Bought a lot more early June 2019.
No sell order either for me, you'd be crazy to bar the first trial results not even coming through yet.
I would only consider placing a sell order if I think the market overreacts to a catalyst i.e the $BIT f*ing crazy pump last year.
I am using our peers, good ones are BOT.ax and AGH.ax as a way to gauge IHL's value compared to theirs, as well as overall market sentiment.
$BOT roughly at 200M MC as of now, $IHL only at 27M MC.
$BOT with one successful phase 1 trial, more in the pipeline and ongoing. Also losing gorillions of cash per quarter, making none.
$IHL with no successful trials to date. 4 in the pipeline funded by CannVaLate to come 2H 2019 and 2020. Losing roughly 300k per quarter, improving every quarter.
Risk v Reward fairly obvious here, even at my most conservative estimates of trial success and perceived market valuation this still has a long way to go from the current SP. DYOR
- Forums
- ASX - By Stock
- IHL
- Ann: Dronabinol Supply Agreement/Sleep Apnoea Trial Update
Ann: Dronabinol Supply Agreement/Sleep Apnoea Trial Update, page-64
-
- There are more pages in this discussion • 65 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IHL (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO & Managing Director
Charles Armstrong
CEO & Managing Director
SPONSORED BY The Market Online